Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 3 medicines
New Zealand
PHARMAC · 2 medicines
All medicines with Meningococcal (groups a, c, y
Every register, a page at a time. Strengths and packs are on each medicine’s page.
13 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenactraCombination | United States | 48UG/.5ML | For Injection | Marketed | Sanofi Vaccines US Inc. |
| MenQuadfiCombination | New Zealand | Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| Menquadfi | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| NimenrixCombination | New Zealand | Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| PenmenvyCombination | United States | 25UG/0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| PenbrayaCombination | United States | 5UG | Injection | Marketed | Pfizer Ireland Pharmaceuticals Unlimited Company |
| Nimenrix | European Union | Authorised | Pfizer Europe MA EEIG | ||
| MenomuneCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| MenhibrixCombination | United States | 0.5ML | Injection | Withdrawn | GlaxoSmithKline Biologicals |
| Meningococcal Polysaccharide Vaccine Groups A & CCombination | Canada | 500 MCG / VIAL + 500 MCG / VIAL | Kit, Powder For Solution | Cancelled | Aventis Pasteur SA |
| Penbraya | European Union | Withdrawn | Pfizer Europe MA EEIG |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Names in the registers
How the registers write it, in their own languages.
- Meningococcal (groups a, c, y,
Sources
Compiled by Prognia from the public medicine registers of FDA and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 2
- Medicines
- 5
- Companies
- 2



